1. Home
  2. SGMT vs AEYE Comparison

SGMT vs AEYE Comparison

Compare SGMT & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$5.74

Market Cap

164.6M

Sector

N/A

ML Signal

HOLD

Logo AudioEye Inc.

AEYE

AudioEye Inc.

HOLD

Current Price

$7.68

Market Cap

170.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMT
AEYE
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
164.6M
170.9M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SGMT
AEYE
Price
$5.74
$7.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
3
Target Price
$27.00
$20.67
AVG Volume (30 Days)
566.6K
150.6K
Earning Date
01-01-0001
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
45.49
28.00
EPS
N/A
N/A
Revenue
$2,000,000.00
$35,201,000.00
Revenue This Year
N/A
$16.81
Revenue Next Year
N/A
$11.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.41
52 Week Low
$1.73
$6.35
52 Week High
$11.41
$16.39

Technical Indicators

Market Signals
Indicator
SGMT
AEYE
Relative Strength Index (RSI) 51.03 50.18
Support Level $5.60 $6.35
Resistance Level $6.72 $12.82
Average True Range (ATR) 0.33 0.44
MACD 0.06 0.19
Stochastic Oscillator 62.78 97.86

Price Performance

Historical Comparison
SGMT
AEYE

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.

Share on Social Networks: